News & Analysis on Clinical Trial Services & Contract Research And Development
Analysts suggest a Trump presidency won’t have a material impact on contract research organizations – though a shake-up in trade policy could complicate the larger, global pharmaceutical industry.
Venn Life Sciences has signed a new contract with Sedana Medical AB worth €2.5m as the CRO continues to reposition itself for growth.
Pfizer has earmarked two sites in the UK for closure, including an ex-Hospira aseptic plant in London it says would need ‘significant investment’ to remain open.
Increasing regulatory burdens are increasing costs and will create fewer, bigger, and better players in the CDMO space, according to Catalent’s CEO.
The first-of-its-kinds “umbrella trial” involves multiple sponsors and collaborators working to accelerate precision therapies.
US public health programmes will use lower dose vaccines administered over longer periods from 2017 if President elect Donald Trump adheres to a plan he outlined last year.
Investigators are more willing to work with sponsors who choose their preferred central lab, according to a recent study.